Haim–Munk syndrome: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Haim–Munk syndrome | |||
| synonyms = [[Cochin Jewish disorder]] | |||
| field = [[Dermatology]], [[Genetics]] | |||
| symptoms = [[Palmoplantar keratoderma]], [[periodontitis]], [[onychogryphosis]], [[acral osteolysis]] | |||
| complications = [[Tooth loss]], [[bone resorption]] | |||
| onset = Childhood | |||
| duration = Lifelong | |||
| types = | |||
| causes = [[Genetic mutation]] in the [[CTSC]] gene | |||
| risks = | |||
| diagnosis = [[Genetic testing]], [[clinical examination]] | |||
| differential = [[Papillon–Lefèvre syndrome]], [[Mal de Meleda]] | |||
| prevention = | |||
| treatment = [[Retinoids]], [[antibiotics]], [[dental care]] | |||
| medication = | |||
| prognosis = Variable, depends on management of symptoms | |||
| frequency = Rare | |||
| deaths = | |||
}} | |||
'''Haim–Munk syndrome''' (HMS) is a rare [[autosomal recessive]] [[genetic disorder]] characterized by a combination of [[palmoplantar keratoderma]], [[periodontitis]], [[onychogryphosis]], and [[acral osteolysis]]. It is named after the physicians [[Seymour Haim]] and [[J. Munk]], who first described the condition. | |||
== Clinical Features == | == Clinical Features == | ||
Haim–Munk syndrome presents with several distinctive clinical features: | |||
* '''Palmoplantar keratoderma''': Thickening of the skin on the palms of the hands and the soles of the feet. | * '''Palmoplantar keratoderma''': Thickening of the skin on the palms of the hands and the soles of the feet. | ||
* '''Periodontitis''': Severe inflammation of the gums leading to early loss of teeth. | * '''Periodontitis''': Severe inflammation of the gums leading to early loss of teeth. | ||
* '''Onychogryphosis''': Abnormal curvature and thickening of the nails. | * '''Onychogryphosis''': Abnormal curvature and thickening of the nails. | ||
* '''Acral osteolysis''': Bone resorption in the distal phalanges, leading to shortening of the fingers and toes. | * '''Acral osteolysis''': Bone resorption in the distal phalanges, leading to shortening of the fingers and toes. | ||
== Genetics == | == Genetics == | ||
Haim–Munk syndrome is inherited in an [[autosomal recessive]] manner. The condition is caused by mutations in the [[CTSC]] gene, which encodes the enzyme [[cathepsin C]]. This enzyme is crucial for the activation of certain [[proteases]] involved in the immune response and skin integrity. | |||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of | Diagnosis of Haim–Munk syndrome is based on clinical evaluation, family history, and genetic testing to identify mutations in the [[CTSC]] gene. Differential diagnosis includes other conditions with similar features, such as [[Papillon–Lefèvre syndrome]]. | ||
== Treatment == | == Treatment == | ||
There is no cure for | There is no cure for Haim–Munk syndrome. Treatment focuses on managing symptoms and may include: | ||
* Regular dental care to manage [[periodontitis]]. | * Regular dental care to manage [[periodontitis]]. | ||
* Use of emollients and keratolytic agents for [[palmoplantar keratoderma]]. | * Use of emollients and keratolytic agents for [[palmoplantar keratoderma]]. | ||
* Surgical intervention for severe [[onychogryphosis]]. | * Surgical intervention for severe [[onychogryphosis]]. | ||
* Monitoring and management of bone resorption in cases of [[acral osteolysis]]. | * Monitoring and management of bone resorption in cases of [[acral osteolysis]]. | ||
== Prognosis == | == Prognosis == | ||
The prognosis for individuals with | The prognosis for individuals with Haim–Munk syndrome varies. Early diagnosis and management of symptoms can improve the quality of life, but the condition can lead to significant morbidity due to dental issues and skin problems. | ||
== Related Pages == | == Related Pages == | ||
* [[Autosomal recessive]] | * [[Autosomal recessive]] | ||
| Line 32: | Line 47: | ||
* [[Acral osteolysis]] | * [[Acral osteolysis]] | ||
* [[CTSC gene]] | * [[CTSC gene]] | ||
* [[ | * [[Papillon–Lefèvre syndrome]] | ||
== See Also == | == See Also == | ||
* [[List of cutaneous conditions]] | * [[List of cutaneous conditions]] | ||
* [[List of genetic disorders]] | * [[List of genetic disorders]] | ||
{{Genetic-disorder-stub}} | {{Genetic-disorder-stub}} | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
Latest revision as of 06:06, 4 April 2025
| Haim–Munk syndrome | |
|---|---|
| Synonyms | Cochin Jewish disorder |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Palmoplantar keratoderma, periodontitis, onychogryphosis, acral osteolysis |
| Complications | Tooth loss, bone resorption |
| Onset | Childhood |
| Duration | Lifelong |
| Types | |
| Causes | Genetic mutation in the CTSC gene |
| Risks | |
| Diagnosis | Genetic testing, clinical examination |
| Differential diagnosis | Papillon–Lefèvre syndrome, Mal de Meleda |
| Prevention | |
| Treatment | Retinoids, antibiotics, dental care |
| Medication | |
| Prognosis | Variable, depends on management of symptoms |
| Frequency | Rare |
| Deaths | |
Haim–Munk syndrome (HMS) is a rare autosomal recessive genetic disorder characterized by a combination of palmoplantar keratoderma, periodontitis, onychogryphosis, and acral osteolysis. It is named after the physicians Seymour Haim and J. Munk, who first described the condition.
Clinical Features[edit]
Haim–Munk syndrome presents with several distinctive clinical features:
- Palmoplantar keratoderma: Thickening of the skin on the palms of the hands and the soles of the feet.
- Periodontitis: Severe inflammation of the gums leading to early loss of teeth.
- Onychogryphosis: Abnormal curvature and thickening of the nails.
- Acral osteolysis: Bone resorption in the distal phalanges, leading to shortening of the fingers and toes.
Genetics[edit]
Haim–Munk syndrome is inherited in an autosomal recessive manner. The condition is caused by mutations in the CTSC gene, which encodes the enzyme cathepsin C. This enzyme is crucial for the activation of certain proteases involved in the immune response and skin integrity.
Diagnosis[edit]
Diagnosis of Haim–Munk syndrome is based on clinical evaluation, family history, and genetic testing to identify mutations in the CTSC gene. Differential diagnosis includes other conditions with similar features, such as Papillon–Lefèvre syndrome.
Treatment[edit]
There is no cure for Haim–Munk syndrome. Treatment focuses on managing symptoms and may include:
- Regular dental care to manage periodontitis.
- Use of emollients and keratolytic agents for palmoplantar keratoderma.
- Surgical intervention for severe onychogryphosis.
- Monitoring and management of bone resorption in cases of acral osteolysis.
Prognosis[edit]
The prognosis for individuals with Haim–Munk syndrome varies. Early diagnosis and management of symptoms can improve the quality of life, but the condition can lead to significant morbidity due to dental issues and skin problems.
Related Pages[edit]
- Autosomal recessive
- Genetic disorder
- Palmoplantar keratoderma
- Periodontitis
- Onychogryphosis
- Acral osteolysis
- CTSC gene
- Papillon–Lefèvre syndrome
See Also[edit]

This article is a genetic disorder stub. You can help WikiMD by expanding it!